Menu

#Genmab

1 post

Feed
1 of 1 post
A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled
📰
0Read More

A little-known biotech’s high-stakes cancer bet just paid off and its shares doubled

US Top News and Analysis·13 days ago
#WFu85Wf6
#cnbc#business#genmab#cancer#billion

Genmab’s shares have doubled in three months after a string of cancer drug trial wins, strengthening its push to own more of the medicines it develops.

15s